Futu News reported on March 15 that the three major indices of Hong Kong stocks fell collectively. At the close, the Hang Seng Index fell 1.42%, the Science Index fell 1.50%, and the National Index fell 1.46%.
By the close, Hong Kong stocks were up 696, down 1,268, and closed at 973.
The specific industry performance is as follows:
On the sector side, TechNet shares generally fell, with Bilibili falling more than 5%, Meituan falling nearly 4%, and Ali, Baidu, Tencent, and Jingdong falling about 2%.
The decline in auto stocks narrowed in the afternoon. NIO fell nearly 4%, while Ideal, Great Wall, Xiaopeng, Geely, and BYD fell by more than 1%, falling slightly from zero.
Domestic housing stocks and property management stocks mostly declined. Vanke Enterprise fell nearly 5%, Longhu Group and China Overseas Development fell more than 3%, Sunac China fell more than 2%, and Country Garden Services fell more than 1%.
CRO concept stocks continued to weaken. Pharmaceutical Biotech fell more than 10%, Pharmaceutical Kangde fell nearly 9%, Tiger Pharmaceuticals fell more than 6%, and Zhaoyan Pharmaceutical fell more than 4%.
Copper stocks rose collectively in the afternoon. China's nonferrous mining industry rose more than 5%, Minmetals resources rose more than 4%, Wanguo International Mining rose nearly 3%, and Jiangxi Copper shares rose nearly 2%.
On the other side, household appliances stocks, military stocks, gambling stocks, port shipping stocks, heavy machinery stocks, coal stocks, etc. all fell; education stocks, environmental protection stocks, and water stocks mostly rose.
In terms of individual stocks,$TUHU-W (09690.HK)$It rose more than 5%. Adjusted net profit for 2023 was 481 million yuan, turning a year-on-year loss into a profit.
$UNITED LAB (03933.HK)$It rose nearly 10%, and profit is expected to rise to about 2.6 billion yuan in 2023.
$WUXI BIO (02269.HK)$The drop was more than 10%. BIO, a well-known American biotechnology organization, was revised and updated. Pharmaceutical Kangde voluntarily terminated its membership.
$LI NING (02331.HK)$With a drop of nearly 4%, Lyon expects its net profit to drop 24% year on year last year, lowering the target price.
Today's top 10 Hong Kong stock turnover
Hong Kong Stock Connect Capital
On the Hong Kong Stock Connect side, today's net inflow of Hong Kong Stock Connect (southbound) was HK$4.166 billion.
Agency Perspectives
Goldman Sachs: Maintaining AIA's “Buy” Rating, Target Price Raised to HK$98
Goldman Sachs released a research report saying it will$AIA (01299.HK)$The target price was slightly raised from HK$97 to HK$98, maintaining the “buy” rating and remaining on the confident buying list. The main reason is that AIA can maintain a strong growth momentum in 2024.
Lyon: Samsonite was given a “buy” rating, and the target price was raised to HK$36
Lyon released a research report saying that$SAMSONITE (01910.HK)$The “buy” rating was raised by 1% of sales for the current year and next, and the net profit forecast was increased by 7% to 9%, while adjusted EBITDA profit is expected to increase by 20 basis points per year during the period, and the target price was raised from HK$32 to HK$36.
UBS: Maintaining Xinao Energy's “neutral” rating and raising the target price to HK$71
UBS released a research report saying investors have been paying attention$ENN ENERGY (02688.HK)$As well as the business competition of the parent company Xinao Co., Ltd. in the upstream and downstream business, it is expected that recent management changes will help restructure the strategic collaboration and development goals between the two companies, and send a more clear signal to the market, believing that the relevant personnel changes will have a positive impact. Maintaining Xinao Energy's “neutral” rating, the target price was raised from HK$53 to HK$71.
editor/tolk
